AI assistant
Sending…
RESMED INC — Director's Dealing 2016
Nov 14, 2016
30071_dirs_2016-11-14_5a344a89-0705-4cad-8e41-6d7595406ee1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-11-11
Reporting Person: Farrell Michael J. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-11 | ResMed Common Stock | F | 6469 | $59.85 | Disposed | 191653 | Direct |
| 2016-11-11 | ResMed Common Stock | F | 8685 | $59.85 | Disposed | 182968 | Direct |
| 2016-11-11 | ResMed Common Stock | F | 8518 | $59.85 | Disposed | 174450 | Direct |
Footnotes
F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/13/2013.
F2: Includes 316 shares of ResMed stock purchased on 10/31/2016, through the ResMed Employee Stock Purchase Plan.
F3: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2014.
F4: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2015.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29